Search Results - "Munitz, H."

Health care disparities among persons with comorbid schizophrenia and cardiovascular disease: a case–control epidemiological study by Gal, G., Munitz, H., Levav, I.

“…Studies showed health care disparities among persons with comorbid schizophrenia and cardiovascular disease (CVD), including in countries with universal health…”
Get full text

Heat Intolerance in Patients With Chronic Schizophrenia Maintained With Antipsychotic Drugs by Hermesh, Haggai, Shiloh, Roni, Epstein, Yoram, Manaim, Hillel, Weizman, Abraham, Munitz, Hanan

“…OBJECTIVE: Schizophrenia may be associated with hyperthermic syndromes such as febrile catatonia, neuroleptic malignant syndrome, and heatstroke. The authors…”
Get full text

Mortality from neuroleptic malignant syndrome by SHALEV, A, HERMESH, H, MUNITZ, H

“…The authors assess the mortality from the neuroleptic malignant syndrome (NMS) based on an exhaustive review of 202 published case reports, including a…”
Get full text

Mianserin or placebo as adjuncts to typical antipsychotics in resistant schizophrenia by Shiloh, R, Zemishlany, Z, Aizenberg, D, Valevski, A, Bodinger, L, Munitz, H, Weizman, A

“…The beneficial effect of atypical antipsychotic drugs (APDs) in treatment-resistant schizophrenia patients has been attributed, mostly, to their relatively…”
Get full text

Familial Expressed Emotion: Outcome and Course of Israeli Patients With Schizophrenia by Marom, Sofi, Munitz, Hanan, Jones, Peter B., Weizman, Abraham, Hermesh, Haggai

“…We investigated the validity of expressed emotion (EE) in Israel. The study sample consisted of 108 patients with schizophrenia and 15 with schizoaffective…”
Get full text

The neuroleptic malignant syndrome: agent and host interaction by Shalev, A, Munitz, H

“…This review comprises an exhaustive analysis of 120 case reports of neuroleptic malignant syndrome (NMS) representing the majority of published clinical data…”
Get more information

Beneficial effect of olanzapine in schizophrenic patients with obsessive-compulsive symptoms by Poyurovsky, M, Dorfman-Etrog, P, Hermesh, H, Munitz, H, Tollefson, G D, Weizman, A

“…Some studies suggest that obsessive-compulsive symptoms may be common (7.8-46%) in schizophrenic patients and seem to be poorly responsive to drug therapy…”
Get more information

Low-dose Clozapine for the treatment of Parkinson's disease in a patient with schizophrenia by ORR, Guy, MUNITZ, Hanan, HERMESH, Haggai

“…Clozapine is known to be beneficial for the treatment of dopamine agonist-induced psychotic states in patients with Parkinson's disease (PD). Many reports have…”
Get full text

Commentaries on "the psychiatry certification examination in Israel" by Munitz, H

Get more information

Association between severity of schizophrenic symptoms and urinary retention by Shiloh, R, Weizman, A, Dorfman-Etrog, P, Weizer, N, Munitz, H

“…A case is presented in which severe urinary retention (UR) occurred during an acute psychotic exacerbation of paranoid schizophrenia. The voiding dysfunction…”
Get full text

Predicting revolving-door patients in a 9-year national sample by RABINOWITZ, J, MARK, M, POPPER, M, SLYUZBERG, M, MUNITZ, H

“…We attempted to predict revolving door (RD) patterns of admission (four or more admissions with less than 2.5 years between consecutive admissions) in a random…”
Get full text

Primary renal lymphoma. Does it exist? by Kandel, L B, McCullough, D L, Harrison, L H, Woodruff, R D, Ahl, Jr, E T, Munitz, H A

“…Although secondary renal involvement from systemic lymphoma is common, primary lymphoma of the kidney is not well recognized. One case is reported and 27 cases…”
Get more information

Cyproheptadine treatment in neuroleptic-induced akathisia by Weiss, D, Aizenberg, D, Hermesh, H, Zemishlany, Z, Munitz, H, Radwan, M, Weizman, A

“…Cyproheptadine, an antiserotonergic agent, was used to treat neuroleptic-induced akathisia. In an open clinical trial 17 neuroleptic-treated patients with…”
Get more information

Poor neuroleptic response in acutely exacerbated schizophrenic patients by Shalev, A, Hermesh, H, Rothberg, J, Munitz, H

“…Poor neuroleptic response is a major unresolved clinical problem. Precise data concerning the frequency of poor neuroleptic response are not available. The…”
Get more information

Antidepressive effect of pyridoxine (vitamin B6) in neuroleptic-treated schizophrenic patients with co-morbid minor depression--preliminary open-label trial by Shiloh, R, Weizman, A, Weizer, N, Dorfman-Etrog, P, Munitz, H

“…Minor depression is reported in 20-60% of schizophrenic patients during various stages of their disorders; impairing patients' compliance, response to…”
Get more information

Possible relevance of alterations at the cellular, neuronal connectivity and brain structure levels to the pathophysiology of schizophrenia by Berger, E, Shiloh, R, Weizman, A, Munitz, H

Get more information

Risk for definite neuroleptic malignant syndrome. A prospective study in 223 consecutive in-patients by Hermesh, H, Aizenberg, D, Weizman, A, Lapidot, M, Mayor, C, Munitz, H

“…The occurrence of neuroleptic malignant syndrome (NMS) was studied prospectively in two series of consecutive psychiatric in-patients (n = 223). The first…”
Get more information

The discriminatory power of psychiatric laws and regulations by Munitz, H

Get full text

Single-contrast vs double-contrast barium enema in the detection of colonic polyps by Ott, DJ, Chen, YM, Gelfand, DW, Wu, WC, Munitz, HA

“…Radiographic and colonoscopic correlation in 139 patients with 234 colonic polyps compared the sensitivity of single- and double-contrast barium enema…”
Get full text

Neuroleptic malignant syndrome during abrupt reduction of neuroleptic treatment by Spivak, B, Weizman, A, Wolovick, L, Hermesh, H, Tyano, S, Munitz, H

“…Development of neuroleptic malignant syndrome (NMS) following discontinuation of high-dose and high-potency neuroleptic agents is described. This case,…”
Get more information